Elevated serum CgA levels were reported in 100% of gastrinomas, 89% of pheochromocytomas, 80% of carcinoids, 50% of medullary thyroid carcinomas, and in 69% of non-functioning Pan-NETs, respectively [44,48,49]. This evidence concerns the gene CGA and medullary thyroid gland carcinoma.